ONKOS is part of the two main Healthcare Innovation Centers in Latin America: a. With 12 convenient Maryland radiology centers, we offer state of the art technology and the highest quality medical imaging available. We have licensed this test patent and commercialization rights to Fleury Group, one of the largest laboratory networks in Latin America. Appointment requests and patient scheduling software. The test evaluates the expression profiling generated by a panel of 95 genes and compares the genetic signatures with a database of 4400 known primary cancers, divided into 25 cancer types. The patient portal mobile app supports all of the features included in Bridge Patient Portal, including: Personal health records. We are providing data that can help physicians on treatment decisions resulting in the patient best care. TOT- Tumor Origin Test, which is a mRNA-based molecular classifier for Metastatic Cancers with Unknown Primary site. The validation study showed a 96% NPV and the test is performed using the readily available smear slides already prepared for prior cytology test. to University Radiology, the largest Board Certified provider of diagnostic imaging and subspecialty radiology services in NJ. To date, we are driving a revolution with a dramatic reduction in unnecessary thyroid surgeries. mir-THYpe®, which is microRNA-based molecular classifier for thyroid nodules with indeterminate cytology. Our current portfolio is composed of the two first gene expression-based tests developed and applied on clinical routine in the southern hemisphere: a. Our Gene Expression Profiling platform merges cutting-edge technologies of molecular biology and artificial intelligence tools to create molecular classifiers that are translated into actionable results to unlock the best care for cancer patients.

that speed the path from raw experimental data to new treatments and diagnostics. Read reviews, compare customer ratings, see screenshots and learn more about Bridge Patient Portal. We guide informed clinical decisions to enable not only the best patient management available but also healthcare providers efficiencies and savings. Seven Bridges is the biomedical data analysis company accelerating. ONKOS is Latin America´s leading startup company provider of proprietary gene expression-based diagnostic tests that is focused on providing answers to diagnostic uncertainties in Oncology by avoiding unnecessary procedures.

Bridge diagnostics patient portal